Mark William Lowdell - 21 Mar 2022 Form 4 Insider Report for Inmune Bio, Inc. (INMB)

Role: Chief Scientific Officer, 10%+ Owner
Signature: /s/ Mark William Lowdell
Issuer symbol: INMB
Transactions as of: 21 Mar 2022
Net transactions value: +$198,864
Form type: 4
Filing time: 23 Mar 2022, 16:35:02 UTC
Previous filing: 04 Nov 2021
Next filing: 23 Apr 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INMB	Common Stock	Award	$198,864	+23,590	+1.6%	$8.43	1,496,383	22 Mar 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INMB	Option (right to buy)	Award	$0	+104,000		$0.000000	104,000	21 Mar 2022	Common Stock	104,000	$7.92	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The purchase price of the common stock being reported is the closing price per share immediately preceding the entering into of the binding agreement to issue the securities. These shares were purchased by the Reporting Person directly from Issuer.
F2	Granted pursuant to the 2021 Stock Incentive Plan. One third (1/3) of the Option will vest at the one-year anniversary of the grant date and the remaining unvested Option will become vested and exercisable 1/24th every month thereafter until the Option is 100% vested which shall occur on the three-year anniversary of the grant date.